MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.oret.2026.09.027

Медицинская библиотека · Ophthalmology. Retina · 2026

Anti-Vascular Endothelial Growth Factor Injection-to-Surgery Interval in Diabetic Vitrectomy: A Systematic Review and Meta-Analysis.

Butt Fahad R, Al-Burak Salem Abu, Abid Fatima, Shad Justin, Sawires Korolos, Popovic BScPharm Marko M, Alfalah Mohammed, Kertes Peter J

СтатьяОбзорПеревод в очереди

Аннотация

TOPIC: To evaluate how outcomes of pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR) vary with the preoperative anti-vascular endothelial growth factor (anti-VEGF) injection-to-surgery interval.

CLINICAL RELEVANCE: Preoperative anti-VEGF facilitates vitrectomy in PDR, but the influence of the interval is unclear; longer intervals may increase fibrovascular contraction and tractional retinal detachment (TRD) risk.

METHODS

This prospectively registered review (CRD420250651229) searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials to March 17, 2026 for comparative studies of PPV for PDR with preoperative anti-VEGF. The prespecified confirmatory comparison was anti-VEGF versus no anti-VEGF, with early postoperative vitreous hemorrhage (VH) as the principal outcome; interval analyses (no anti-VEGF, 1 to 3, 4 to 7, 8 to 14, and more than 14 days) were exploratory. Odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were pooled using random-effects models (restricted maximum likelihood, Hartung-Knapp, prediction intervals) and sensitivity models for sparse events and clustered arms. Certainty of evidence was rated separately for the anti-VEGF effect and interval effects.

RESULTS

Thirty-three studies (3,419 eyes; 12 randomized) were included. Anti-VEGF was associated with lower early postoperative VH (OR, 0.40; 95% CI, 0.23 to 0.69), lower intraoperative VH (OR, 0.20; 95% CI, 0.10 to 0.40), fewer reoperations (OR, 0.58; 95% CI, 0.41 to 0.82), and less endodiathermy (OR, 0.21; 95% CI, 0.10 to 0.43). Final visual acuity was slightly better but heterogeneous (MD, -0.15 logarithm of the minimum angle of resolution; 95% CI, -0.29 to 0.00). Late VH, retinal detachment, silicone oil use, and TRD did not differ. Single-group proportions were lowest at 1 to 3 and 4 to 7 days, but the interval modeled continuously was not associated with either hemorrhage outcome. Certainty was moderate for early postoperative VH and low to very low otherwise.

CONCLUSION

Preoperative anti-VEGF is associated with less intraoperative and early postoperative hemorrhage and fewer reoperations at diabetic vitrectomy, with the lowest hemorrhage rates when injection precedes surgery by 1 to 7 days. The evidence does not identify a precise optimal interval; higher TRD and reoperation rates beyond 14 days derive from a single cohort. Interval associations are hypothesis-generating given observational, low-certainty evidence.

Для цитирования: Butt Fahad R, Al-Burak Salem Abu, Abid Fatima, Shad Justin, Sawires Korolos, Popovic BScPharm Marko M, Alfalah Mohammed, Kertes Peter J. Anti-Vascular Endothelial Growth Factor Injection-to-Surgery Interval in Diabetic Vitrectomy: A Systematic Review and Meta-Analysis.. Ophthalmology. Retina. 2026. DOI: 10.1016/j.oret.2026.09.027.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.